Wny Asset Management, LLC Gilead Sciences, Inc. Transaction History

Wny Asset Management, LLC

$826 Million
Q3 2024

A detailed history of Wny Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wny Asset Management, LLC holds 33,911 shares of GILD stock, worth $3.19 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

33,911

Previous 52,863 35.85%

Holding current value

$3.19 Million

Previous $3.63 Million 21.62%

% of portfolio

0.34%

Previous 0.5%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $1.26 Million - $1.59 Million	-18,952 Reduced 35.85%	33,911 $2.84 Million
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $1.2 Million - $1.39 Million	19,071 Added 56.44%	52,863 $3.63 Million
Q1 2024 May 07, 2024	BUY	$71.58 - $87.29 $219,607 - $267,805	3,068 Added 9.99%	33,792 $2.48 Million
Q4 2023 Feb 21, 2024	BUY	$73.27 - $83.09 $286,998 - $325,463	3,917 Added 14.61%	30,724 $2.49 Million
Q3 2023 Dec 14, 2023	BUY	$73.94 - $80.67 $421,605 - $459,980	5,702 Added 27.02%	26,807 $2.01 Million
Q2 2023 Aug 03, 2023	SELL	$76.01 - $86.7 $202,870 - $231,402	-2,669 Reduced 11.23%	21,105 $1.63 Million
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $748,592 - $852,878	-9,683 Reduced 28.94%	23,774 $1.97 Million
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $1.46 Million - $2.1 Million	-23,504 Reduced 41.26%	33,457 $0
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $423,091 - $483,279	7,106 Added 14.25%	56,961 $3.51 Million
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $430,648 - $485,039	7,461 Added 17.6%	49,855 $3.08 Million
Q1 2022 Apr 19, 2022	BUY	$57.92 - $72.58 $758,983 - $951,088	13,104 Added 44.74%	42,394 $2.53 Million
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $434,631 - $493,314	6,699 Added 29.65%	29,290 $2.13 Million
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $76,151 - $82,158	-1,125 Reduced 4.74%	22,591 $1.57 Million
Q2 2021 Jul 14, 2021	BUY	$63.47 - $69.35 $601,759 - $657,507	9,481 Added 66.6%	23,716 $1.63 Million
Q1 2021 Apr 20, 2021	BUY	$60.0 - $68.46 $854,100 - $974,528	14,235 New	14,235 $920,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wny Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wny Asset Management, LLC with notifications on news.

Account

Wny Asset Management, LLC Gilead Sciences, Inc. Transaction History